Departments of Endocrinology and Metabolism Cardiology, Academic Medical Centre, University of Amsterdam, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Eur J Endocrinol. 2011 Jan;164(1):107-13. doi: 10.1530/EJE-10-0785. Epub 2010 Oct 18.
To evaluate the progression in time from euthyroidism to overt autoimmune hypothyroidism or to overt autoimmune hyperthyroidism.
The design is that of a nested case-control study within the prospective Amsterdam autoimmune thyroid disease (AITD) cohort study in which 790 healthy euthyroid women with at least one first or second degree relative with documented AITD were followed for 5 years. Thyroid function tests were assessed annually. Contrast between cases (overt hypothyroidism - TSH>5.7 mU/l and free thyroxine (FT(4))<9.3 pmol/l and overt hyperthyroidism - TSH<0.4 mU/l and FT(4)>20.1 pmol/l, also referred to as events) and controls (matched for age and duration of follow-up).
At baseline, the 38 hypothyroid cases had already higher TSH and lower FT(4) concentrations than their 76 controls, and the difference between both the groups persisted 1 year before occurrence of the event. In contrast, neither TSH nor FT(4) values differed between the 13 hyperthyroid cases and their 26 controls at baseline or 1 year before the event. The prevalence of thyroid peroxidase-Ab was higher in both hypothyroid and hyperthyroid cases than in controls. At the time of event, hypothyroid cases were less common among current smokers (P=0.083) and more common in the postpartum period (P=0.006) than their controls, whereas hyperthyroid cases were pregnant more frequently (P=0.063).
The data suggest that progression toward overt autoimmune hypothyroidism is a gradual process taking several years, but in contrast overt autoimmune hyperthyroidism develops faster in terms of months.
评估从甲状腺功能正常到显性自身免疫性甲状腺功能减退症或显性自身免疫性甲状腺功能亢进症的时间进展。
这是一项嵌套病例对照研究,研究对象为前瞻性阿姆斯特丹自身免疫性甲状腺疾病(AITD)队列研究中的 790 名健康甲状腺功能正常的女性,这些女性至少有一位一级或二级亲属患有明确的 AITD,并随访 5 年。每年评估甲状腺功能检查。病例(TSH>5.7 mU/l 和游离甲状腺素(FT4)<9.3 pmol/l 的显性甲状腺功能减退症和 TSH<0.4 mU/l 和 FT4>20.1 pmol/l 的显性甲状腺功能亢进症,也称为事件)与对照组(年龄和随访时间匹配)进行对比。
在基线时,38 例甲状腺功能减退症患者的 TSH 已经较高,FT4 浓度较低,与 76 名对照组相比,这种差异在事件发生前 1 年持续存在。相比之下,13 例甲状腺功能亢进症患者及其 26 名对照组在基线或事件发生前 1 年的 TSH 或 FT4 值均无差异。甲状腺过氧化物酶抗体在甲状腺功能减退症和甲状腺功能亢进症患者中均较对照组更为常见。在发生事件时,甲状腺功能减退症患者中当前吸烟者(P=0.083)较少,而产后患者(P=0.006)较对照组更为常见,而甲状腺功能亢进症患者怀孕的频率更高(P=0.063)。
这些数据表明,向显性自身免疫性甲状腺功能减退症的进展是一个需要数年的渐进过程,但相比之下,显性自身免疫性甲状腺功能亢进症的发展速度更快,仅需数月。